People with epilepsy have a higher risk for migraines, and now new research offers evidence of a genetic link between the two conditions.
LATEST EFGC NEWS
The coach opened it up for questions, and a little boy raised his hand. The child could have asked Jerry Kill anything, anything at all, and he would have gotten a straight answer. The Kill way is to tell the truth, even if the truth isn’t too optimistic. The Minnesota head coach learned that as a boy growing up in a tiny Kansas town with a dad who spit truth like sunflower seeds. So this little boy was going to get the truth, even in front of a group of fans in neighboring Wisconsin, even if he asked why the Gophers never beat Michigan, and never beat Ohio State.
Besides helping to boost mood, antidepressants may also reduce seizure frequency for people with epilepsy, a new study suggests.
This collection of “Now I Know” videos was filmed at the 2012 Epilepsy Foundation of Greater Chicago Consumer Conference, held on November 17, 2012 in Chicago, Illinois. These short videos were filmed using a laptop digital camera, and were completely unrehearsed. The collection shows the variety of experience among those living with epilepsy, and highlights the concept of knowledge, and how it is often derived from personal discovery and perseverance.
Let’s all take part in National Epilepsy Awareness Month! The Epilepsy Foundation has multiple activities going on and there are many ways you can get involved… from sharing your experiences with epilepsy in an online video campaign, to attending our third annual Epilepsy Consumer Conference. This is a great opportunity to come together to educate ourselves and the general public about epilepsy.
A prescription medication originally developed to treat epilepsy may help obese adults shed weight when combined with routine nutritional counseling, researchers say.
The U.S. attorney’s office in Chicago filed a federal civil rights lawsuit Monday against a recreational organization in Crystal Lake that serves children and adults with disabilities, alleging it has refused to administer a specific epilepsy medication to two participants.